Chewy Becomes the Latest Stock Pick of Roaring Kitty
Chewy stock is volatile Monday after Keith Gill, the investor known as Roaring Kitty, disclosed a 6.6% stake in the online pet retailer.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered daily
Kiplinger Today
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more delivered daily. Smart money moves start here.
Sent five days a week
Kiplinger A Step Ahead
Get practical help to make better financial decisions in your everyday life, from spending to savings on top deals.
Delivered daily
Kiplinger Closing Bell
Get today's biggest financial and investing headlines delivered to your inbox every day the U.S. stock market is open.
Sent twice a week
Kiplinger Adviser Intel
Financial pros across the country share best practices and fresh tactics to preserve and grow your wealth.
Delivered weekly
Kiplinger Tax Tips
Trim your federal and state tax bills with practical tax-planning and tax-cutting strategies.
Sent twice a week
Kiplinger Retirement Tips
Your twice-a-week guide to planning and enjoying a financially secure and richly rewarding retirement
Sent bimonthly.
Kiplinger Adviser Angle
Insights for advisers, wealth managers and other financial professionals.
Sent twice a week
Kiplinger Investing Weekly
Your twice-a-week roundup of promising stocks, funds, companies and industries you should consider, ones you should avoid, and why.
Sent weekly for six weeks
Kiplinger Invest for Retirement
Your step-by-step six-part series on how to invest for retirement, from devising a successful strategy to exactly which investments to choose.
Chewy (CHWY) stock was trading more than 26% higher in Monday's pre-market session after Keith Gill, the investor also known as Roaring Kitty, disclosed a noteworthy position in the online pet food and products retailer. However, the stock quickly came back down to earth and was last seen 6% lower.
In a filing with the Securities and Exchange Commission (SEC), Gill disclosed a 6.6% stake in Chewy worth just over $245 million based on Friday's closing price of $27.24. In total, Gill owns roughly 9 million shares of the consumer discretionary stock.
Roaring Kitty helped spark a massive short squeeze in GameStop (GME) stock back in 2021 and returned to the spotlight with a cryptic post on X in mid-May, igniting another round of meme stock mania.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Gill apparently now has his sights set on Chewy. The pet supplies company was founded by Ryan Cohen in 2011, and he was CEO of the CHWY until 2018. Cohen has since left Chewy and is now chairman and CEO of GameStop.
Is Chewy stock a buy, sell or hold?
After a slow start to the year, Chewy is now up over 60% in the past three months thanks in part to a solid fiscal first-quarter earnings report. And Wall Street is bullish on the stock. According to S&P Global Market Intelligence, the consensus recommendation among the 28 analysts following CHWY that it tracks is a Buy.
However, analysts' price targets have struggled to keep up with CHWY’s surging share price in recent months. Currently, the average price target of $26.08 is right around where the stock stands today.
Financial services firm Wedbush is one of the more bullish outfits on CHWY stock with a Buy rating at $28 price target.
"CHWY continues to gain market share and materially expand margins in a weak industry environment while the company indicated encouraging pet household formation trends with net adoptions turning positive for the first time since 2022," Wedbush analyst Seth Basham said in a May 30 note following Chewy's earnings release. "Additionally, benefits from cross-sales of pharmacy products continues to drive net spending per average customer (NSPAC) higher with further room for improvement and additional upside potential if industry demand normalizes."
Wedbush's $28 price target represents implied upside of roughly 10% to current levels.
Related Content
-
Dow Leads in Mixed Session on Amgen Earnings: Stock Market TodayThe rest of Wall Street struggled as Advanced Micro Devices earnings caused a chip-stock sell-off.
-
How to Watch the 2026 Winter Olympics Without OverpayingHere’s how to stream the 2026 Winter Olympics live, including low-cost viewing options, Peacock access and ways to catch your favorite athletes and events from anywhere.
-
Here’s How to Stream the Super Bowl for LessWe'll show you the least expensive ways to stream football's biggest event.
-
Dow Leads in Mixed Session on Amgen Earnings: Stock Market Today
The rest of Wall Street struggled as Advanced Micro Devices earnings caused a chip-stock sell-off.
-
How to Add a Pet Trust to Your Estate Plan: Don't Leave Your Best Friend to ChanceAdding a pet trust to your estate plan can ensure your pets are properly looked after when you're no longer able to care for them. This is how to go about it.
-
Want to Avoid Leaving Chaos in Your Wake? Don't Leave Behind an Outdated Estate PlanAn outdated or incomplete estate plan could cause confusion for those handling your affairs at a difficult time. This guide highlights what to update and when.
-
I'm a Financial Adviser: This Is Why I Became an Advocate for Fee-Only Financial AdviceCan financial advisers who earn commissions on product sales give clients the best advice? For one professional, changing track was the clear choice.
-
Nasdaq Slides 1.4% on Big Tech Questions: Stock Market TodayPalantir Technologies proves at least one publicly traded company can spend a lot of money on AI and make a lot of money on AI.
-
I Met With 100-Plus Advisers to Develop This Road Map for Adopting AIFor financial advisers eager to embrace AI but unsure where to start, this road map will help you integrate the right tools and safeguards into your work.
-
The Referral Revolution: How to Grow Your Business With TrustYou can attract ideal clients by focusing on value and leveraging your current relationships to create a referral-based practice.
-
This Is How You Can Land a Job You'll Love"Work How You Are Wired" leads job seekers on a journey of self-discovery that could help them snag the job of their dreams.
